Kindstar Globalgene Technology, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Kindstar Globalgene Technology, Inc. - overview
Established
2003
Location
Wuhan, Hubei, China
Primary Industry
Healthcare
About
Founded in 2003 and based in Wuhan, China, Kindstar Globalgene Technology, Inc. , also known as Kindstar, is an esoteric testing service provider that provides specialized diagnosis, treatment, and personalized medicine services. Kindstar provides specialized laboratories for testing and testing platforms such as PCR (real-time PCR) platform, gene chip platform (Affymetrix), liquid chip platform (Luminex), mass spectrometry platform (Sequenom), digital gene platform (NanoString), and other types of clinical pathology and testing platform. As of 2021, the company has 38,000 square meters of clinical testing and R&D center in Beijing, Shanghai, Wuhan, Xinjiang, Chengdu, and Tianjin in China.
Current Investors
Kleiner Perkins, WI Harper Group, Baird Capital Partners Asia
Primary Industry
Healthcare
Sub Industries
Biotechnology, Diagnostic, Medical & Imaging Laboratories, Healthcare Specialists, Medical Devices & Equipment, Pharmaceutical Research & Development
Website
www.kindstar.com.cn
Verticals
HealthTech
Company Stage
Mature
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.